LeMaitre Vascular Recalls Vascular Graft due to Serious Adverse Events

- by

Washington, DC: The Food and Drug Administration has issued a Class 1 Recall of the LeMaitre Vascular, Inc. Albograft Vascular Graft due to blood leaking from the surface of the graft after implantation. This product may cause serious adverse health consequences, including death.

Within the U.S., this device was only distributed in Pennsylvania.

This device was manufactured in April 2011, and distributed from April 2011, through June 2013.

The Albograft Vascular Graft is made of synthetic material. It is designed to replace or repair a damaged artery with an abnormal enlargement (aneurysm) or a blockage (occlusion) caused by a disease.

On June 19 2013, the firm sent an Urgent Field Safety Notice dated June 19, 2013, to all affected customers. Affected models are: AMC1408, AMC1506, AMC1608, AMC1809, AMC1810, AMC2010, AMC4007, AMC4008, AMC6006, AMC6007, AMC6008, ATC1526, ATC1530, ATC3016, ATC3018, ATC3024, ATC3026, Batch 56890A

Legal Help

If you or a loved one has suffered similar damages or injuries, please fill in our form on the right and your complaint will be sent to a lawyer who may evaluate your claim at no cost or obligation.

Add Your Comment on This Issue

Please read our comment guidelines before posting.

Note: Your name will be published with your comment.

Your email will only be used if a response is needed.

Request Legal Help